New Haven, CT · Founded 2013 · Privately Held (backing)
Developer of a precision therapeutics technology designed to treat cancer and rare diseases. OrphAI Therapeutics is based in New Haven, CT and was founded in 2013. Its last known valuation is $300 million. It has raised $155 million.
Last price · $/share
—
Implied valuation
$300.0M
Total raised
$154.5M
Last round
—
Cap table — not yet on record
OrphAI Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of OrphAI Therapeutics with a free account
·Watch OrphAI Therapeutics: the Monday email on marks, rounds and moves
